Lilly Follows Upbeat Trials for Cholesterol Shot with $4B M&A Spree
Lilly Follows Upbeat Trials for Cholesterol Shot with $4B M&A Spree
Lilly Follows Upbeat Trials for Cholesterol Shot with $4B M&A Spree
Summary aggregated from Yahoo Finance's public RSS feed. The full reporting belongs to Yahoo Finance — please read it on their site.